Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APP13007 for post-cataract surgery inflammation and pain
CTR20232560Phase 3Completed
- Sponsor
- TaiMed Biologics
- Start
- Aug 2023
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of GPN00833 in Postoperative ocular inflammation, post-operative ocular pain, sponsored by TaiMed Biologics. Started Aug 2023; status: completed.
02
Drugs
GPN00833
03
Conditions
Postoperative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on CTR20232560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232560.